Resolution of Citalopram Sexual Adverse Effects With Low Dose of Cariprazine: A Case Report

2020 ◽  
Vol 43 (5) ◽  
pp. 164-165
Author(s):  
Massimiliano Dieci ◽  
Annalisa Trama ◽  
Gianluigi Mansi
Keyword(s):  
Case Report ◽  
Adverse Effects ◽  
Low Dose

scholarly journals Monthly low-dose immunoglobulin infusion as a maintenance therapy for multifocal motor neuropathy may reduce allergic adverse effects: A case report

2010 ◽  
Vol 50 (8) ◽  
pp. 561-565
Author(s):  
Yoshiko Murata ◽  
Tomoko Okamoto ◽  
Yoshiyuki Kondo ◽  
Norio Chihara ◽  
Yoshihiko Furusawa ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Effects ◽  
Maintenance Therapy ◽  
Low Dose ◽  
Multifocal Motor Neuropathy ◽  
Motor Neuropathy

scholarly journals Rapid-onset supraventricular tachycardia following clozapine initiation and its management with verapamil: a case report

2019 ◽  
Vol 6 (2) ◽  
pp. 547
Author(s):  
Afnan A. Alwabili
Keyword(s):  
Case Report ◽  
Side Effects ◽  
Adverse Effects ◽  
Supraventricular Tachycardia ◽  
Low Dose ◽  
Rapid Onset ◽  
Treatment Resistant ◽  
Early Stages ◽  
Drug Of Choice ◽  
Cardiovascular Side Effects

Clozapine is the drug of choice for treatment-resistant schizophrenia. However, the use of clozapine is limited by its serious adverse effects, which often underlie its discontinuation. The cardiovascular side effects that raise safety concerns include tachycardia, myocarditis and cardiomyopathy. The development of clozapine-induced tachycardia is usually observed on higher dosage especially at early stages of treatment. Here, author presented the case of a patient with treatment-resistant schizophrenia who developed asymptotic supraventricular tachycardia despite low dose of clozapine at the second day of treatment. Additionally, author explored the possibility of clozapine re-challenge in combination with verapamil treatment.

Intravenous Ethchlorvynol-Induced Pulmonary Edema

1979 ◽  
Vol 13 (2) ◽  
pp. 96-99 ◽  
Author(s):  
Timothy H. Self ◽  
Francis F. Fountain ◽  
Robert Dunnebacke ◽  
Michael Pipkin ◽  
Herb Patterson
Keyword(s):  
Case Report ◽  
Adverse Effects ◽  
Pulmonary Edema ◽  
Respiratory Symptoms ◽  
Low Dose ◽  
X Ray ◽  
Pulmonary Infiltrates ◽  
Chest X Ray ◽  
Pertinent Feature

A case report of intravenous ethchlorvynol-induced pulmonary edema is presented. Approximately 450 mg of ethchlorvynol was withdrawn from a Placidyl® capsule and injected by a 30-year-old man. Respiratory symptoms occurred within twenty minutes and a chest X-ray taken within two hours revealed diffuse bilateral pulmonary infiltrates. The patient's condition improved rapidly. A pertinent feature of the case is the comparatively low dose of ethchlorvynol which caused pulmonary edema. It is also of note that two colleagues of the patient did not have evidence of any adverse effects after injecting approximately 180 mg of ethchlorvynol.

Resting Tremor during Low-dose Tricyclic Antidepressant Treatment - A case report -

2007 ◽  
Vol 20 (1) ◽  
pp. 71
Author(s):  
Young Bok Lee ◽  
Jong Taek Park ◽  
Ja Youn Jeon ◽  
Kwang Ho Lee
Keyword(s):  
Case Report ◽  
Low Dose ◽  
Antidepressant Treatment ◽  
Tricyclic Antidepressant ◽  
Resting Tremor

scholarly journals Delayed-Type Hypersensitivity Reaction to Red Tattoo Ink Triggered by Ledipasvir/Sofosbuvir for Hepatitis C: A Case Report

2021 ◽  
pp. 379-383
Author(s):  
Meghan L. McPhie ◽  
Kevin Y.M. Ren ◽  
J. Michael Hendry ◽  
Sonja Molin ◽  
Thomas Herzinger
Keyword(s):  
Case Report ◽  
Hepatitis C ◽  
Adverse Effects ◽  
Hypersensitivity Reaction ◽  
Allergic Reaction ◽  
Delayed Type Hypersensitivity ◽  
Histological Features

Tattoos have become increasingly popular worldwide making adverse effects from tattoos a growing concern. In our report, we present a 51-year-old man who developed an unusual allergic reaction to the red ink portions of his tattoos that coincided with the initiation of ledipasvir/sofosbuvir treatment for his hepatitis C. Clinical and histological features were consistent with a delayed-type hypersensitivity reaction to red ink.

scholarly journals Plaque erosion causing ST-elevation myocardial infarction after consumption of cannabis and N2O in a 27-year old man: a case report

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sarah Bär ◽  
Fabien Praz ◽  
Lorenz Räber
Keyword(s):  
Myocardial Infarction ◽  
Case Report ◽  
Adverse Effects ◽  
Cardiovascular Effects ◽  
Drug Eluting Stent ◽  
Culprit Lesion ◽  
Vascular Events ◽  
The Public ◽  
Plaque Erosion ◽  
First Case

Abstract Background The recreational drugs cannabis and nitrous oxide (N2O) are known for pro-atherogenic effects and are associated with an elevated risk of myocardial infarction. These cardiovascular effects might be underestimated by the public. Culprit-lesion composition of myocardial infarctions associated with cannabis and N2O has been unknown so far. This case report aims to raise the awareness of the adverse cardiovascular effects of cannabis and N2O and reports, for the first time, optical coherence tomography (OCT) findings of the culprit lesion. Case presentation This is a case report of a 27-year old man with anterior ST-segment-elevation myocardial infarction (STEMI) after intoxication with cannabis and N2O. Coronary angiography and OCT revealed plaque erosion with subsequent subtotal thrombotic occlusion of the left anterior descending artery that was successfully treated with 1 drug-eluting stent. The patient was symptom free at 6 months follow-up and had been able to abstain from drug consumption. Conclusions This is the first case to demonstrate the association between cannabis and N2O abuse and plaque erosion on OCT in a young man with STEMI. In contrast to smoking, whose adverse effects are well-known, the cardiovascular effects of cannabis and N2O might be underestimated. These adverse effects should gain more awareness in the public to prevent early vascular events in young adults.

Sign in / Sign up

Export Citation Format

Share Document